city London bc coronavirus Coronavirus Vaccine Coronavirus city London

Vancouver biotech firm could play key role in developing COVID-19 vaccine

Reading now: 634
globalnews.ca

COVID-19 vaccines to market.Acuitas Therapeutics is currently partnering with three teams, including one backed by drug giant Pfizer and one out of Imperial College London, who have entered Phase I/II clinical vaccine trials.BioNTech, which has partnered with Pfizer, began its trials back in April, while CureVac and Imperial College began trials last month.

Potential coronavirus vaccine has ‘right sort of immune response’ in trial: scientist  Acuitas president Tom Madden says researchers are hoping to use Messenger RNA to create an immune response that defends against COVID-19.Acuitas’ role in the vaccines is the creation of a delivery method to get that material into the body.“We provide microscopic carriers, lipid nanoparticles, that.

Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA